Corvus Pharmaceuticals publishes soquelitinib Phase 1 T cell data in Blood

August 27, 2026 7:30 AM

Corvus Pharmaceuticals (Nasdaq: CRVS) announced the publication of peer-reviewed final data from its Phase 1/1b trial of soquelitinib in patients ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found